
1602: Net Equity
Long COVID Serotonin Study, Prozac Treatment Proposals
Researchers at the University of Pennsylvania have identified low serotonin levels in the gut as a potential cause for Long COVID symptoms. The study suggests that viral persistence leads to inflammation that prevents tryptophan absorption. Media coverage of the study is criticized as a "native ad" for SSRIs like Prozac as a solution for neurocognitive symptoms.





